ArticleFrontiers in neurology2025
Comparison of SPECT/CT, AEEG, and 3D-pCASL in people with epilepsy.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on abdominal epilepsy in children.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the clinical value of single-photon emission computed tomography (SPECT)/computed tomography (CT), ambulatory electroencephalogram (AEEG) and three-dimensional pseudo-continuous arterial spin labeling (3D-pCASL) in people with epilepsy (PWE). Methods: The study included 98 PWE who were treated in The General Hospital of Ningxia Medical University from December 2021 to September 2023. The positive detection rates and characteristics of SPECT/CT, AEEG and 3D-pCASL were compared. Additionally, the agreement between SPECT/CT, 3D-pCASL and AEEG-positive results was analyzed. Results: The positive detection rates for SPECT/CT, AEEG, and 3D-pCASL examinations were 77.55% (76/98), 62.24% (61/98), and 54.08% (53/98) respectively. SPECT/CT exhibited higher positive detection rates than AEEG (aOR = 1.165, 95%CI: 1.036-1.311, Conclusion: SPECT/CT demonstrated a high positive detection rate and showed strong agreement with AEEG-positive results in PWE. The combined use of SPECT/CT, AEEG and 3D-pCASL significantly increased the positive detection rate. These findings highlight the advantages of SPECT/CT and combined modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.